open access

Vol 7, No 3 (2011)
Case report
Published online: 2011-08-23
Get Citation

Anaplastic large cell lymphoma — three different entities

Paweł Kurczab
Onkol. Prak. Klin 2011;7(3):146-151.

open access

Vol 7, No 3 (2011)
CASE REPORT
Published online: 2011-08-23

Abstract

Anaplastic large cell lymphoma (ALCL) is rare entity derived from T-lymphocytes. In the classification of World Health Organisation (WHO) ALCL is divided into cutaneous and two systemic types (ALK+ and ALK–), differring in terms of clinical features, genetic changes and partly histopathology and immunophenotype. Proper diagnosis is crucial and determines treatment. I present a case of 61-year-old woman with resistant to treatment systemic ALK-type of ALCL and briefly describe this disease entity.
Onkol. Prak. Klin. 2011; 7, 3: 146–151

Abstract

Anaplastic large cell lymphoma (ALCL) is rare entity derived from T-lymphocytes. In the classification of World Health Organisation (WHO) ALCL is divided into cutaneous and two systemic types (ALK+ and ALK–), differring in terms of clinical features, genetic changes and partly histopathology and immunophenotype. Proper diagnosis is crucial and determines treatment. I present a case of 61-year-old woman with resistant to treatment systemic ALK-type of ALCL and briefly describe this disease entity.
Onkol. Prak. Klin. 2011; 7, 3: 146–151
Get Citation

Keywords

anaplastic large cell lymphoma; anaplastic lymphoma kinase; chemotherapy; radiotherapy

About this article
Title

Anaplastic large cell lymphoma — three different entities

Journal

Oncology in Clinical Practice

Issue

Vol 7, No 3 (2011)

Article type

Case report

Pages

146-151

Published online

2011-08-23

Bibliographic record

Onkol. Prak. Klin 2011;7(3):146-151.

Keywords

anaplastic large cell lymphoma
anaplastic lymphoma kinase
chemotherapy
radiotherapy

Authors

Paweł Kurczab

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl